Capital Wealth Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605M Buy
4,708,599
+191,869
+4% +$22.5M 3.02% 13
2026
Q1
$543M Sell
4,516,730
-487,467
-10% -$56.3M 3% 17
2025
Q4
$529M Buy
5,004,197
+1,812,755
+57% +$170M 3.43% 15
2025
Q3
$268M Buy
3,191,442
+1,604,656
+101% +$132M 1.89% 22
2025
Q2
$126M Buy
1,586,786
+1,582,939
+41,147% +$126M 0.99% 25
2025
Q1
$345K Sell
3,847
-2,056,814
-100% -$192M ﹤0.01% 121
2024
Q4
$205M Sell
2,060,661
-1,023,662
-33% -$106M 1.9% 23
2024
Q3
$350M Buy
3,084,323
+114,890
+4% +$13.6M 3.27% 15
2024
Q2
$368M Buy
2,969,433
+701,481
+31% +$90.4M 3.85% 13
2024
Q1
$299M Sell
2,267,952
-245,543
-10% -$30.3M 3.2% 14
2023
Q4
$274M Sell
2,513,495
-932,081
-27% -$96.8M 3.14% 14
2023
Q3
$355M Sell
3,445,576
-35,904
-1% -$3.87M 4.36% 11
2023
Q2
$402M Buy
3,481,480
+1,285,693
+59% +$146M 4.96% 9
2023
Q1
$284M Sell
2,195,787
-1,332,686
-38% -$144M 3.84% 14
2022
Q4
$391M Buy
3,528,473
+289,305
+9% +$29.6M 5.72% 3
2022
Q3
$279M Buy
3,239,168
+710,813
+28% +$63.5M 5.09% 7
2022
Q2
$231M Buy
2,528,355
+1,242,586
+97% +$110M 4.51% 12
2022
Q1
$105M Buy
1,285,769
+1,278,331
+17,186% +$101M 2.13% 22
2021
Q4
$570K Sell
7,438
-7,557
-50% -$602K 0.01% 63
2021
Q3
$1.13M Sell
14,995
-1,837
-11% -$140K 0.03% 44
2021
Q2
$1.31M Sell
16,832
-539
-3% -$40.1K 0.04% 45
2021
Q1
$1.28M Sell
17,371
-848
-5% -$62.6K 0.04% 47
2020
Q4
$1.41M Sell
18,219
-740,383
-98% -$56.6M 0.05% 45
2020
Q3
$60M Buy
758,602
+48,082
+7% +$3.77M 2.97% 16
2020
Q2
$52.4M Sell
710,520
-234,727
-25% -$17.7M 2.99% 15
2020
Q1
$69.4M Buy
945,247
+61,201
+7% +$4.81M 4.37% 7
2019
Q4
$76.7M Buy
884,046
+343,594
+64% +$28.2M 4.53% 6
2019
Q3
$42.6M Sell
540,452
-197,978
-27% -$15.9M 2.7% 17
2019
Q2
$59.1M Buy
738,430
+698,989
+1,772% +$53.5M 4.28% 8
2019
Q1
$3.13M Buy
39,441
+31,581
+402% +$2.36M 2.05% 12
2018
Q4
$573K Hold
7,860
0.38% 39
2018
Q3
$532K Hold
7,860
0.36% 41
2018
Q2
$455K Hold
7,860
0.32% 45
2018
Q1
$409K Buy
+7,860
New +$425K 0.28% 47
2017
Q4
Sell
-8,384
Closed -$512K 143
2017
Q3
$512K Sell
8,384
-413,303
-98% -$25.1M 0.4% 41
2017
Q2
$25.8M Buy
421,687
+413,303
+4,930% +$25.2M 4.13% 11
2017
Q1
$508K Hold
8,384
0.43% 33
2016
Q4
$471K Hold
8,384
0.42% 34
2016
Q3
$499K Hold
8,384
0.39% 36
2016
Q2
$464K Hold
8,384
0.35% 49
2016
Q1
$423K Hold
8,384
0.3% 49
2015
Q4
$423K Hold
8,384
0.39% 52
2015
Q3
$395K Hold
8,384
0.31% 57
2015
Q2
$455K Sell
8,384
-4,192
-33% -$235K 0.27% 64
2015
Q1
$690K Sell
12,576
-262
-2% -$14.8K 0.36% 59
2014
Q4
$695K Hold
12,838
0.32% 63
2014
Q3
$726K Hold
12,838
0.29% 63
2014
Q2
$709K Hold
12,838
0.26% 68
2014
Q1
$695K Buy
+12,838
New +$665K 0.3% 58
2013
Q4
Sell
-8,384
Closed -$381K 111
2013
Q3
$381K Buy
+8,384
New +$383K 0.17% 89

Other funds holding MRK

Capital Wealth Planning's MRK Position: Q2 2026 in Review

Capital Wealth Planning increased its Merck (MRK) stake by 4.2% in Q2 2026, buying an estimated $22.5M and bringing the position to 4,708,599 shares worth $605M. The position accounts for 3.02% of the portfolio, ranked #13.

Capital Wealth Planning first reported a position in MRK in Q3 2013 and has held it in 50 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Wealth Planning held 4,708,599 shares of Merck worth $605M as of Q2 2026.
  • Capital Wealth Planning bought 191,869 Merck shares in Q2 2026, an estimated $22.5M.
  • Merck made up 3.02% of Capital Wealth Planning's portfolio in Q2 2026, its #13 holding.
  • Capital Wealth Planning first reported a position in Merck in Q3 2013 and has held it in 50 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Wealth Planning's 13F filing for Q2 2026, filed 14 Aug 2026.